Characterization of metalloprotease cleavage products of human articular cartilage.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Arthritis & Rheumatism

• Publication date

  2008-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/art.23654PMID 18668564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Establishment of a Reliable Method for Direct Proteome Characterization of Human Articular Cartilage*

  2006cited by this paper
• Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis.

  2006cited by this paper
• Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation.

  2006cited by this paper
• Collagen Biomarkers for Arthritis Applications

  2006cited by this paper
• The cleavage of biglycan by aggrecanases.

  2006cited by this paper
• MRI and non-cartilaginous structures in knee osteoarthritis.

  2006cited by this paper
• The utility of measuring C-terminal telopeptides of collagen type II (CTX-II) in serum and synovial fluid samples for estimation of articular cartilage status in experimental models of destructive joint diseases.

  2006cited by this paper
• Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.

  2006cited by this paper
• The role of collagenolytic matrix metalloproteinases in the loss of articular cartilage in osteoarthritis.

  2006cited by this paper
• Modulation of cell-fibronectin matrix interactions during tissue repair.

  2006cited by this paper
• Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis

  2005cited by this paper
• Comparative Effect of Nimesulide and Ibuprofen on the Urinary Levels of Collagen Type II C-Telopeptide Degradation Products and on the Serum Levels of Hyaluronan and Matrix Metalloproteinases-3 and -13 in Patients with Flare-Up of Osteoarthritis

  2005cited by this paper
• Pathogenesis and management of pain in osteoarthritis.

  2005cited by this paper
• MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis

  2005cited by this paper
• Comprehensive label-free method for the relative quantification of proteins from biological samples.

  2005cited by this paper
• Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.

  2005cited by this paper
• Cleavage of Fibromodulin in Cartilage Explants Involves Removal of the N-terminal Tyrosine Sulfate-rich Region by Proteolysis at a Site That Is Sensitive to Matrix Metalloproteinase-13*

  2004cited by this paper
• Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).

  2004cited by this paper
• MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis

  2004cited by this paper
• A comparison of magnetic resonance imaging, sonography, and radiography of the hand in patients with early rheumatoid arthritis.

  2004cited by this paper
• Endothelin 1 promotes osteoarthritic cartilage degradation via matrix metalloprotease 1 and matrix metalloprotease 13 induction.

  2003cited by this paper
• Complexes of Matrilin-1 and Biglycan or Decorin Connect Collagen VI Microfibrils to Both Collagen II and Aggrecan*

  2003cited by this paper
• Aggrecanases and cartilage matrix degradation

  2003cited by this paper
• Pathophysiological Mechanisms in Osteoarthritis Lead to Novel Therapeutic Strategies

  2003cited by this paper
• Urinary collagen type II C-telopeptide fragments are sensitive markers of matrix metalloproteinase-dependent cartilage degradation in rat adjuvant-induced arthritis.

  2003cited by this paper
• Focal Adhesion Kinase and Mitogen-activated Protein Kinases Are Involved in Chondrocyte Activation by the 29-kDa Amino-terminal Fibronectin Fragment*

  2002cited by this paper
• Collagen type II C-telopeptide fragments as an index of cartilage degradation.

  2001cited by this paper
• Clusterin expression in adult human normal and osteoarthritic articular cartilage.

  2001cited by this paper
• Serum YKL-40 is associated with osteoarthritis and atherosclerosis in nonhuman primates.

  2001cited by this paper
• Analysis of collagenase-cleavage of type II collagen using a neoepitope ELISA.

  2001cited by this paper
• Expression of both P1 and P2 purine receptor genes by human articular chondrocytes and profile of ligand-mediated prostaglandin E2 release.

  1999cited by this paper
• Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis.

  1999cited by this paper
• Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project.

  1999cited by this paper
• Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.

  1997cited by this paper
• Increased degradation and alteered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage

  1996cited by this paper
• The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis.

  1996cited by this paper
• Biochemical Characterization of Human Collagenase-3 (*)

  1996cited by this paper
• Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage

  1996cited by this paper
• Diagnostic radiography in rheumatoid arthritis: benefits and limitations.

  1996cited by this paper
• Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.

  1996cited by this paper
• 9 – Cellular Biology of Cartilage Degradation

  1995cited by this paper
• Matrix Metalloproteinase-2 Is an Interstitial Collagenase

  1995cited by this paper
• Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments.

  1995cited by this paper
• Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis.

  1994cited by this paper
• Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1.

  1994cited by this paper
• Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture.

  1992cited by this paper
• Metalloproteinase digestion of cartilage proteoglycan. Pattern of cleavage by stromelysin and susceptibility to collagenase.

  1991cited by this paper
• Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin).

  1990cited by this paper
• Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes.

  1987cited by this paper
• The tensile properties of the cartilage of human femoral condyles related to the content of collagen and glycosaminoglycans.

  1973cited by this paper

• Lumican as a potential biomarker for diabetic nephropathy

  2025cites this paper
• Cartilage targeting cationic peptide carriers display deep cartilage penetration and retention in a rabbit model of post-traumatic osteoarthritis.

  2025cites this paper
• Characterization of ADAMTS9 proteoglycanase activity: Comparison with ADAMTS1, ADAMTS4, and ADAMTS5

  2025cites this paper
• Nanopeptides-Loaded Electro-Assembled Oriented Collagen Matrix for the Synergistically Promotes Early Angiogenesis in Tendon Healing.

  2025cites this paper
• Therapeutic potential of COMP and TIMP-3 in preserving cartilage integrity compromised by proteases: A histo-mechanical study.

  2025cites this paper
• Association of Urinary Collagen Type III Degradation Product With Kidney Function and Fibrosis in Chronic Kidney Disease Patients

  2025cites this paper
• Integrin signalling in joint development, homeostasis and osteoarthritis

  2024cites this paper
• Cathepsin D is essential for the degradomic shift of macrophages required to resolve liver fibrosis

  2024cites this paper
• From biochemical markers to molecular endotypes of osteoarthritis: a review on validated biomarkers

  2024influential citation
• An Introductory Guide to Protease Sensitive Linker Design Using Matrix Metalloproteinase 13 as an Example.

  2024cites this paper
• Cleavage of Cartilage Oligomeric Matrix Protein (COMP) by ADAMTS4 generates a neoepitope associated with osteoarthritis and other forms of degenerative joint disease

  2024cites this paper
• Load-induced blood marker kinetics in patients with medial knee compartment osteoarthritis are associated with accumulated load and patient reported outcome measures

  2023cites this paper
• Purification and Isolation of Proteins from Hyaline Cartilage.

  2023cites this paper
• Controlled extracellular proteolysis of thrombospondins.

  2023cites this paper
• A novel biomarker of MMP-cleaved cartilage intermediate layer protein-1 is elevated in patients with rheumatoid arthritis, ankylosing spondylitis and osteoarthritis

  2023cites this paper
• Cartilage Extracellular Matrix-derived Matrikines in Osteoarthritis.

  2022cites this paper
• Generation of Matrix Degradation Products Using an In Vitro MMP Cleavage Assay

  2022cites this paper
• Forward and reverse degradomics defines the proteolytic landscape of human knee osteoarthritic cartilage and the role of the serine protease HtrA1.

  2022cites this paper
• THE ROLE OF CARTILAGE INTERMEDIATE LAYER PROTEIN2 (CILP2) IN EVALUATING THE EFFECT OF TREATMENTS (PLATELET-RICH PLASMA AND HYALURONIC ACID) ON PATIENTS WITH EARLY KNEE OSTEOARTHRITIS

  2022cites this paper
• Inflammatory Biomarkers of Extracellular Matrix Remodeling and Disease Activity in Crohn’s Disease and Ulcerative Colitis

  2022cites this paper
• Blood and urine biomarkers in osteoarthritis – an update on cartilage associated type II collagen and aggrecan markers

  2021cites this paper
• IGF-1 Upregulates Biglycan and Decorin by Increasing Translation and Reducing ADAMTS5 Expression

  2021cites this paper
• Biomarkers of Joint Damage in Osteoarthritis: Current Status and Future Directions

  2021influential citation
• Heterogeneity in proline hydroxylation of fibrillar collagens observed by mass spectrometry

  2021cites this paper
• Soluble biological markers in osteoarthritis

  2021cites this paper
• The use of aliskiren as an antifibrotic drug in experimental models: A systematic review

  2020cites this paper
• Collagen analysis with mass spectrometry.

  2020cites this paper
• Preparation and Application of a Decellularized Extracellular Matrix for Identification of ADAMTS Substrates.

  2020cites this paper
• Adrenoceptor Expression during Intervertebral Disc Degeneration

  2020cites this paper
• From Translation to Protein Degradation as Mechanisms for Regulating Biological Functions: A Review on the SLRP Family in Skeletal Tissues

  2020cites this paper
• A novel biomarker of MMP-cleaved prolargin is elevated in patients with psoriatic arthritis

  2020cites this paper
• Cartilage Oligomeric Matrix Protein–Derived Peptides Secreted by Cartilage Do Not Induce Responses Commonly Observed during Osteoarthritis

  2020cites this paper
• Keratan Sulphate in the Tumour Environment.

  2020cites this paper
• ADAMTS‐5: A difficult teenager turning 20

  2020cites this paper
• Common confounders when evaluating noninvasive protein biomarkers

  2019cites this paper
• Potential diagnostic value of a type X collagen neo-epitope biomarker for knee osteoarthritis.

  2019cites this paper
• Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin

  2019cites this paper
• Blood and urinary collagen markers in osteoarthritis: markers of tissue turnover and disease activity

  2019cites this paper
• Structural studies of the MMP-3 interaction with triple-helical collagen introduce new roles for the enzyme in tissue remodelling

  2019cites this paper
• Tissue-Derived Biological Particles Restore Cornea Properties in an Enzyme-Mediated Corneal Ectatic Model

  2019cites this paper
• Advances in Molecular biomarker for early diagnosis of Osteoarthritis

  2019cites this paper
• Matrix metalloproteinase-2: Not (just) a "hero" of the past.

  2019cites this paper
• Analysis of Endogenous Peptides Released from Osteoarthritic Cartilage Unravels Novel Pathogenic Markers

  2019cites this paper
• A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes.

  2018cites this paper
• Protease target prediction via matrix factorization

  2018cites this paper
• Investigating TLR-4 signalling in response to protein ligands

  2018cites this paper
• Identification and characterization of biomarkers reflecting extracellular matrix remodeling in cancer

  2018cites this paper
• Catabolism of Fibromodulin in Developmental Rudiment and Pathologic Articular Cartilage Demonstrates Novel Roles for MMP-13 and ADAMTS-4 in C-terminal Processing of SLRPs

  2018influential citation
• The inner ear proteome of fish

  2018cites this paper
• Extracellular matrix constitution and function for tissue regeneration and repair

  2018cites this paper
• Changes in synovial fluid and serum concentrations of cartilage oligomeric matrix protein over 5 years after anterior cruciate ligament rupture: an exploratory analysis in the KANON trial.

  2018cites this paper
• Novel Roles for MMP-13 and ADAMTS-4 in C-terminal Processing of SLRPs

  2018influential citation
• High-molecular-weight hyaluronic acid attenuated matrix metalloproteinase-1 and -3 expression via CD44 in tendinopathy

  2017cites this paper
• Proteoglycan and Collagen Degradation in Osteoarthritis

  2017cites this paper
• Changes in Cartilage Biomarker Levels During a Transcontinental Multistage Footrace Over 4486 km

  2017influential citation
• Chondrocyte secretome: a source of novel insights and exploratory biomarkers of osteoarthritis.

  2017cites this paper
• Cathepsin-S degraded decorin are elevated in fibrotic lung disorders – development and biological validation of a new serum biomarker

  2017cites this paper
• Quantification of cartilage oligomeric matrix protein (COMP) and a COMP neoepitope in synovial fluid of patients with different joint disorders by novel automated assays.

  2017cites this paper
• Cartilage matrix remodelling differs by disease state and joint type.

  2017cites this paper
• Early Cartilage Degeneration: Correlation of Micro-Structural and Proteomic Analysis

  2017cites this paper
• Histopathological changes in supraspinous ligaments, ligamentum flava and paraspinal muscle tissues of patients with ankylosing spondylitis

  2016cites this paper
• University of Southern Denmark Prospective Clinical Trial for Septic Arthritis Cartilage Degradation and Inflammation Are Associated with Upregulation of Cartilage Metabolites

  2016cites this paper
• Prospective Clinical Trial for Septic Arthritis: Cartilage Degradation and Inflammation Are Associated with Upregulation of Cartilage Metabolites

  2016cites this paper
• Urinary collagen degradation products as early markers of progressive renal fibrosis

  2016cites this paper
• Intercritical circulating levels of neo-epitopes reflecting matrixmetalloprotease-driven degradation as markers of gout and frequent gout attacks.

  2016cites this paper
• ADAMTS5 deficiency protects against non‐alcoholic steatohepatitis in obesity

  2016cites this paper
• The diverse functions of osteoglycin: a deceitful dwarf, or a master regulator of disease?

  2016cites this paper
• Proteases decode the extracellular matrix cryptome.

  2016cites this paper
• The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity*

  2016influential citation
• Path to Collagenolysis

  2016cites this paper
• Novel Elements of the Chondrocyte Stress Response Identified Using an in Vitro Model of Mouse Cartilage Degradation.

  2016cites this paper
• Why does my joint hurt: Understanding disease phenotype and pain relationships using mouse models of arthritis

  2016cites this paper
• Readily adaptable release kinetics of prodrugs using protease-dependent reversible PEGylation.

  2016cites this paper
• ADAMTS5 promotes murine adipogenesis and visceral adipose tissue expansion

  2016cites this paper
• Interleukin-1α induces focal degradation of biglycan and tissue degeneration in an in-vitro ovine meniscal model.

  2016cites this paper
• Neo-Epitopes—Fragments of Cartilage and Connective Tissue Degradation in Early Rheumatoid Arthritis and Unclassified Arthritis

  2016cites this paper
• Elucidating the Molecular Architecture of Cartilage by Proteomics

  2015cites this paper
• Collagen-mimetic peptide-modifiable hydrogels for articular cartilage regeneration

  2015cites this paper
• Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseases.

  2015cites this paper
• The Spanish biology/disease initiative within the human proteome project: Application to rheumatic diseases.

  2015cites this paper
• Characterization of neopeptides in equine articular cartilage degradation

  2015influential citation
• TLR4 signalling in osteoarthritis—finding targets for candidate DMOADs

  2015cites this paper
• Lessons from the proteomic study of osteoarthritis

  2015cites this paper
• Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review.

  2015cites this paper
• Bioactivity in an Aggrecan 32‐mer Fragment Is Mediated via Toll‐like Receptor 2

  2015cites this paper
• Tenascin-C: Form versus function

  2014cites this paper
• Cartilage oligomeric matrix protein and its binding partners in the cartilage extracellular matrix: interaction, regulation and role in chondrogenesis.

  2014cites this paper
• Biomarkers of cartilage and surrounding joint tissue.

  2014cites this paper
• The Recognition of Collagen and Triple-helical Toolkit Peptides by MMP-13

  2014cites this paper
• High resistance of the mechanical properties of the chondrocyte pericellular matrix to proteoglycan digestion by chondroitinase, aggrecanase, or hyaluronidase.

  2014cites this paper
• Biomarkers and proteomic analysis of osteoarthritis.

  2014cites this paper
• Soluble biglycan as a biomarker of inflammatory renal diseases.

  2014cites this paper
• The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21

  2014cites this paper
• Matrix-assisted laser desorption ionization-imaging mass spectrometry: a new methodology to study human osteoarthritic cartilage.

  2013cites this paper
• Metalloproteases and tendinopathy.

  2013cites this paper
• Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension

  2013cites this paper
• Expression of HGF, MMP-9 and TGF-β1 in the CSF and cerebral tissue of adult rats with hydrocephalus

  2013cites this paper
• Atherofibrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis - lessons for biomarker development.

  2013cites this paper
• Extracellular Matrix Remodeling: The Common Denominator in Connective Tissue Diseases Possibilities for Evaluation and Current Understanding of the Matrix as More Than a Passive Architecture, but a Key Player in Tissue Failure

  2013cites this paper
• Protein and transcriptome signatures of cartilage ageing and disease

  2013influential citation